Atossa Genetics (ATOS) Stock: Gaining On The Release Of Data

What We’re Seeing From The Stock 

One of the first things that we learn as investors is that the news moves the market. In this particular case, the news proved to be overwhelmingly positive. After all, strong study results are always a great thing. So, it’s no surprise to see that Atossa Genetics is making a run for the top. As is almost always the case, our partners at Trade Ideas were the first to alert us to the gains. Currently (8:27), ATOS is trading at $0.76 per share after a gain of $0.05 per share or 6.52% thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll  Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on ATOS. In particular, we’re interested in following the ongoing work surrounding Endoxifen as the treatment seems to be overwhelmingly promising. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required

Add Comment